The DOI matches its Crossref record; 227 of the 229 references it cites were found in a registry or an index.
Glutamate abnormalities in obsessive compulsive disorder: Neurobiology, pathophysiology, and treatment
Open accessAbstract
Obsessive compulsive disorder is prevalent, disabling, incompletely understood, and often resistant to current therapies. Established treatments consist of specialized cognitive-behavioral psychotherapy and pharmacotherapy with medications targeting serotonergic and dopaminergic neurotransmission. However, remission is rare, and more than a quarter of OCD sufferers receive little or no benefit from these approaches, even when they are optimally delivered. New insights into the disorder, and new treatment strategies, are urgently needed. Recent evidence suggests that the ubiquitous excitatory neurotransmitter glutamate is dysregulated in OCD, and that this dysregulation may contribute to the pathophysiology of the disorder. Here we review the current state of this evidence, including neuroimaging studies, genetics, neurochemical investigations, and insights from animal models. Finally, we review recent findings from small clinical trials of glutamate-modulating medications in treatment-refractory OCD. The precise role of glutamate dysregulation in OCD remains unclear, and we lack blinded, well-controlled studies demonstrating therapeutic benefit from glutamate-modulating agents. Nevertheless, the evidence supporting some important perturbation of glutamate in the disorder is increasingly strong. This new perspective on the pathophysiology of OCD, which complements the older focus on monoaminergic neurotransmission, constitutes an important focus of current research and a promising area for the ongoing development of new therapeutics.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“structural abnormalities in CSTC circuits involving orbitofrontal cortex (OFC), anterior cingulate cortex (ACC), and striatum have been repeatedly demonstrated in OCD 51–53.”
From DISSECTING OCD CIRCUITS: FROM ANIMAL MODELS TO TARGETED TREATMENTS: Review: Dissecting OCD Circuits: Animals to Treatments (2015) · cites this paper as [51]
In the citing paper
“The role of this glutamate transporter gene in OCD is also supported by the observation that the anti-glutamatergic drug riluzole can be beneficial in the treatment of OCD and by the finding of elevated glutamate levels in the CSF of OCD patients (Pittenger et al. 2011).”
From The neurobiological link between OCD and ADHD (2014) · cites this paper as Pittenger et al. 2011
In the citing paper
“Studies using neurochemical and neuroimaging methods have shown that various neurotransmitters are implicated in the pathophysiology of this disorder, including serotonin [1], dopamine [2] and glutamate [3].”
From P300 and delay-discounting in obsessive–compulsive disorder (2022) · cites this paper as [3]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Diagnostic and Statistical Manual of Mental Disorders
Williams, J. B. W., & First, M. B. (2013) · Oxford University Press eBooks · doi:10.1093/acrefore/9780199975839.013.104 · Cited by 109,845
Kessler, R. C., Berglund, P., Demler, O., Jin, R., Merikangas, K. R., & Walters, E. E. (2005) · Archives of General Psychiatry · doi:10.1001/archpsyc.62.6.593 · Cited by 20,391
Diagnostic and Statistical Manual of Mental Disorders.
Widiger, T. A. (2000) · Oxford University Press eBooks · doi:10.1037/10518-009 · Cited by 19,766
Danbolt, N. C. (2001) · Progress in Neurobiology · doi:10.1016/s0301-0082(00)00067-8 · Cited by 4,227
Antidepressant effects of ketamine in depressed patients
Berman, R. M., Cappiello, A., Anand, A., Oren, D. A., Heninger, G. R., Charney, D. S., & Krystal, J. H. (2000) · Biological Psychiatry · doi:10.1016/s0006-3223(99)00230-9 · Cited by 3,856
A randomized trial of an N-methyl-D-aspartate antagonist in treatment-resistant major depression.
Zarate, C. A., Singh, J. B., Carlson, P. J., Brutsche, N. E., Ameli, R., Luckenbaugh, D. A., Charney, D. S., & Manji, H. K. (2006) · Archives of General Psychiatry · doi:10.1001/archpsyc.63.8.856 · Cited by 3,766
The Synaptic Organization of the Brain
(2004) · Oxford University Press eBooks · doi:10.1093/acprof:oso/9780195159561.001.1 · Cited by 3,574
The epidemiology of obsessive-compulsive disorder in the National Comorbidity Survey Replication
Ruscio, A. M., Stein, D. J., Chiu, W. T., & Kessler, R. C. (2010) · Molecular Psychiatry · doi:10.1038/mp.2008.94 · Cited by 2,771
Lifetime Prevalence of Specific Psychiatric Disorders in Three Sites
Robins, L. N. (1984) · Archives of General Psychiatry · doi:10.1001/archpsyc.1984.01790210031005 · Cited by 2,550
Rothstein, J. D., Dykes-Hoberg, M., Pardo, C. A., Bristol, L. A., Jin, L., Kuncl, R. W., Kanai, Y., Hediger, M. A., Wang, Y., Schielke, J. P., et al. (1996) · Neuron · doi:10.1016/s0896-6273(00)80086-0 · Cited by 2,534
Flagged first, then by citations
2 of the 229 references couldn’t be matched to a known paper.
Cited by
Sorted by citations
Items 301–400 of 423
Biological Mechanisms and Treatment of Obsessive–Compulsive Disorder
Pittenger, C. (2026) · Annual Review of Clinical Psychology · doi:10.1146/annurev-clinpsy-081423-020516 · Cited by 6
Self-citationMarmureanu, M., Besoiu, M. V., Dionisie, V., Manea, M. C., Pleșea-Condratovici, C., Voican, S. I., & Manea, M. (2026) · Pharmaceuticals · doi:10.3390/ph19040628 · Cited by 2
Cortical Neurodynamics, Schizophrenia, Depression, and Obsessive-Compulsive Disorder
Rolls, E. T. (2024) · Springer eBooks · doi:10.1007/978-3-031-38391-5_11 · Cited by 2
Aizawa, S., Sakai, T., & Sakata, I. (2014) · Springer eBooks · doi:10.1007/978-1-4939-1932-1_5 · Cited by 2
Metabolic and toxicological considerations for obsessive–compulsive disorder drug therapy
Sayyah, M., Majzoob, S., & Sayyah, M. (2013) · Expert Opinion on Drug Metabolism & Toxicology · doi:10.1517/17425255.2013.783011 · Cited by 2
Vloet, T. D., Herpertz‐Dahlmann, B., & Simons, M. (2016) · Zeitschrift für Kinder- und Jugendpsychiatrie und Psychotherapie · doi:10.1024/1422-4917/a000445 · Cited by 2
Passionate Love Addiction: An Evolutionary Survival Mechanism That Can Go Terribly Wrong
Bolshakova, M., Fisher, H. E., Aubin, H., & Sussman, S. Y. (2020) · Cambridge University Press eBooks · doi:10.1017/9781108632591.026 · Cited by 2
Philosophical Issues in the Addictions
Glackin, S. N. (2020) · Cambridge University Press eBooks · doi:10.1017/9781108632591.007 · Cited by 2
(2020) · Cambridge University Press eBooks · doi:10.1017/9781108632591.020 · Cited by 2
Szechtman, H., Shivji, S., & Woody, E. Z. (2022) · Springer eBooks · doi:10.1007/978-3-031-15080-7_118 · Cited by 3
Guo, X., Lin, W., Zhong, R., Han, Y., Yu, J., Yan, K., Zhang, X., & Liang, J. (2023) · Epilepsy & Behavior · doi:10.1016/j.yebeh.2023.109362 · Cited by 2
Neurobiology of Tic Disorders and Obsessive–Compulsive Disorder
Pittenger, C. (2025) · Oxford University Press eBooks · doi:10.1093/med/9780197640654.003.0065 · Cited by 1
Self-citationCognitive-Behavioral Therapy of Obsessive-Compulsive Disorder in Children and Adolescents
Çimen, İ. D. (2018) · InTech eBooks · doi:10.5772/intechopen.70612 · Cited by 2
Gaigher, T., Tosta, C. L., Herbst, L. S., & Beijamini, V. (2020) · Neuroscience Letters · doi:10.1016/j.neulet.2020.135018 · Cited by 2
Chimakurthy, J., Murthy, T. E. G. K., & Diwan, P. V. (2019) · Indian Journal of Pharmaceutical Sciences · doi:10.36468/pharmaceutical-sciences.527 · Cited by 1
Bakhshinejad, B., Khazaneha, M., Mehrabani, M., Sabahi, A., Sadatmoosavi, A., Tajedini, O., Esmaeili, O., & Mehrbani, M. (2024) · Research Journal of Pharmacy and Technology · doi:10.52711/0974-360x.2024.00047 · Cited by 1
Role of Glutamatergic Modulators in the Treatment of Obsessive Compulsive and Related Disorders
Çelik, F. G. H., & Hocaoğlu, Ç. (2024) · Psikiyatride Guncel Yaklasimlar - Current Approaches in Psychiatry · doi:10.18863/pgy.1279927 · Cited by 2
Neuroglia in Tourette syndrome and obsessive-compulsive disorder
Frick, L. R. (2025) · Handbook of clinical neurology · doi:10.1016/b978-0-443-19102-2.00005-3 · Cited by 1
Obsessive-compulsive disorder and temporal lobe porencephaly: a case report
Deng, G., Cao, Y., & Qiu, C. (2025) · BMC Psychiatry · doi:10.1186/s12888-025-06774-8 · Cited by 1
Deyama, S., Mishiro, K., Kunishima, M., & Kaneda, K. (2025) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2025.178301 · Cited by 1
Suo, X., Zhang, Y., Li, X., Xu, Z., Zeng, L., Lei, L., Zhang, M., Luo, Z., Xia, L., Zeng, X., et al. (2025) · Behavioural Brain Research · doi:10.1016/j.bbr.2025.115962 · Cited by 1
Karagyaur, M. N., Averina, O. A., Дмитриевич, Б. К., Станиславович, Д. С., Priymak, A. V., Permyakov, O. A., Grigorieva, O., Illarionova, M. E., Shkarina, L. N., Primak, A. L., et al. (2025) · Vestnik nevrologii psihiatrii i nejrohirurgii (Bulletin of Neurology Psychiatry and Neurosurgery) · doi:10.33920/med-01-2511-08 · Cited by 1
Restifo-Bernstein, G., Guo, J., Kegeles, L. S., Shungu, D. C., & Simpson, H. B. (2026) · Journal of Mood and Anxiety Disorders · doi:10.1016/j.xjmad.2026.100168 · Cited by 1
López-Rodríguez, S., Segalàs, C., Real, E., Urretavizcaya, M., Bertolín, S., Menchón, J. M., & Alonso, M. D. P. (2026) · BMC Psychiatry · doi:10.1186/s12888-026-08119-5 · Cited by 1
Shahtou, A., Omara, H. R., Qari, S. A., Alqahtani, R. S., Alnasyan, Z. S., Alotaibi, A. E., Ali, A. A., Alabdulrahim, J. M., Naser, S. A., Asad, N., et al. (2026) · Cureus · doi:10.7759/cureus.108358 · Cited by 1
Gong, Y., Bai, Z.-L., Liu, X., Zhang, Q., Wang, S., Liu, F., & Dai, X.-Q. (2013) · Applied Magnetic Resonance · doi:10.1007/s00723-013-0500-8 · Cited by 1
N-Acetylcysteine for the Treatment of Obsessive-Compulsive Disorder
Fritzen, F., & Bloch, M. H. (2014) · Current Psychiatry Reviews · doi:10.2174/1573400510666140807005327 · Cited by 1
Self-citationExcoriation: What Counselors Need to Know About Skin Picking Disorder
Jagger, G. E., & Sterner, W. R. (2016) · Journal of Mental Health Counseling · doi:10.17744/mehc.38.4.01 · Cited by 1
Prevention and Treatment of Work Addiction
Quiñones, C., & Griffiths, M. D. (2020) · Cambridge University Press eBooks · doi:10.1017/9781108632591.028 · Cited by 2
Sussman, S. Y. (2020) · Cambridge University Press eBooks · doi:10.1017/9781108632591.003 · Cited by 1
Voderholzer, U. (2017) · Springer eBooks · doi:10.1007/978-3-662-49295-6_70 · Cited by 1
Chapter 14. Obsessive-Compulsive and Related Disorders
Dougherty, D. D., Wilhelm, S., & Jenike, M. A. (2019) · American Psychiatric Association Publishing eBooks · doi:10.1176/appi.books.9781615372980.lr14 · Cited by 1
Structural and resting-state connection abnormalities of habenula in obsessive-compulsive disorder
Liu, Q., Wang, X., Cao, Y., Gao, F., Xia, J., Du, H., Liao, H., Tan, C., Fan, J., & Zhu, X. (2024) · Psychological Medicine · doi:10.1017/s003329172400045x · Cited by 1
The Role of Immune-Inflammatory Factors in the Pathophysiology of Obsessive–Compulsive Disorder
Xu, X., Li, Z., Wan, S., & Xiao, C. (2024) · Integrated science · doi:10.1007/978-3-031-72079-6_10 · Cited by 1
Sachdev, R. A., Ruparelia, R., Reid, J. E., Mpavenda, D., Cinosi, E., & Fineberg, N. A. (2018) · Cambridge University Press eBooks · doi:10.1017/9781108164313.016 · Cited by 1
Adolescent Drug Misuse Prevention: Challenges in School-Based Programming
Scheier, L. M. (2020) · Cambridge University Press eBooks · doi:10.1017/9781108632591.021 · Cited by 1
Measurement, Prevention, and Treatment of Exercise Addiction
Hausenblas, H. A., Mann, D. T. Y., & Downs, D. S. (2020) · Cambridge University Press eBooks · doi:10.1017/9781108632591.036 · Cited by 2
Neurochemistry of Childhood Anxiety Disorders
Havel, L. K., Mehta, P., Gautam, A., Danielyan, E., & Saxena, K. (2022) · Springer eBooks · doi:10.1007/978-3-031-14080-8_5 · Cited by 1
Seo, E. H., Kim, S.-G., Lee, J.-H., & Yoon, H. (2023) · Clinical Psychopharmacology and Neuroscience · doi:10.9758/cpn.22.1044 · Cited by 1
Costa, D. L. D. C. (2016) · Digital Library of Theses and Dissertations (Universidade de São Paulo) · doi:10.11606/t.5.2016.tde-05122016-164417 · Cited by 1
Biological Models and Treatments for OCD in Adults
Stewart, S. E., & Loh, A. S. (2017) · Wiley eBooks · doi:10.1002/9781118890233.ch14 · Cited by 1
Low-level Chlorpyrifos Exposure Affects Synaptic Plasticity in Hippocampal NeuronsPreprint
Zhou, W., Zhang, C., Wang, P., Deng, Y., Dai, H., Qiong, X., Tian, J., Zhao, M., Wu, G., & Zhao, L. (2021) · Research Square · doi:10.21203/rs.3.rs-377989/v1 · Cited by 1
Korkmaz, N. D., Elibol, B., Durmus, Z. B., Ozdemir, A., Akbaş, F., Gülöksüz, S., & Şahbaz, Ç. (2025) · SSRN Electronic Journal · doi:10.2139/ssrn.5135082 · Cited by 1
The Sapap3-knockout mouse model manifests a spectrum of repetitive behavioursPreprint
Lamothe, H., Schreiweis, C., Mallet, L., & Burguière, E. (2021) · HAL · doi:10.1101/2020.01.22.915215
Cellular Mechanism of Obsessive-Compulsive Disorder
Tee, L. Y. (2015) · DukeSpace (Duke University)
de Leeuw, A. S. (2013) · Utrecht University Repository (Utrecht University)
Variações raras no genoma de pacientes com transtorno obsessivo-compulsivo
Cappi, C. (2013) · Digital Library of Theses and Dissertations (Universidade de São Paulo) · doi:10.11606/t.5.2013.tde-09092013-160344
Naguy, A. (2015) · Journal of psychiatry · doi:10.4172/2378-5756.1000291
Social dysfunction and mental retardation
Pietropaolo, S., Sluyter, F., & Crusio, W. E. (2014) · Cambridge University Press eBooks · doi:10.1017/cbo9781107360556.010
Garnier, A., Vidal, A. C., & Benali, H. (2015) · arXiv (Cornell University) · doi:10.48550/arxiv.1510.01313
Perlado, F. L., Mentxaka-Solozabal, O., Diaz-Guardamino, E. M., Rivas, M. C., Erazo-Presser, P., & Miranda-Artieda, Z. M. (2013)
Scarff, J. R. (2014) · The Internet Journal of Psychiatry
Obsessive–compulsive disorder and Gilles de la Tourette syndrome
Woehrle, N. S., & Dulawa, S. C. (2014) · Cambridge University Press eBooks · doi:10.1017/cbo9781107360556.016
Emerging Data for Ketamine in Obsessive-Compulsive, Stress-Related, and Substance Use Disorders
Rodríguez, C. I., & Dakwar, E. (2016) · Springer eBooks · doi:10.1007/978-3-319-42925-0_9
Integrative Therapie der Zwangsstörungen
Voderholzer, U. (2016) · Springer eBooks · doi:10.1007/978-3-642-45028-0_70-1
The Molecular Genetics of Obsessive-Compulsive and Related Disorders
Kohlrausch, F. B. (2018) · Cambridge University Press eBooks · doi:10.1017/9781108164313.005 · Cited by 1
Şengül, Y., Yılmaz, O., Sengul, H., Yıldız, F. B. P., & Öztürk, A. (2019) · Bezmialem Science · doi:10.14235/bas.galenos.2018.2607
Compton, W. M., & Blanco, C. (2020) · Cambridge University Press eBooks · doi:10.1017/9781108632591.001
Novel Psychoactive Substances: A New Challenge for Prevention and Treatment
Kapitány‐Fövény, M., Corazza, O., Marrinan, S., & Demetrovics, Z. (2020) · Cambridge University Press eBooks · doi:10.1017/9781108632591.032
Human Laboratory Paradigms in Addictions Research
Morris, V. L., Arshad, F., Balodis, I. M., Reed, D. D., MacKillop, J. M., & Amlung, M. T. (2020) · Cambridge University Press eBooks · doi:10.1017/9781108632591.010
Anhedonia in Addictive Behaviors
Dyer, W. G., Leventhal, A. M., Goldenson, N. I., & Bello, M. S. (2020) · Cambridge University Press eBooks · doi:10.1017/9781108632591.039
American Legal Issues in Addiction Treatment and Research
Willick, D. H. (2020) · Cambridge University Press eBooks · doi:10.1017/9781108632591.041
Strack, R. W., Orsini, M. M., Ewald, D. R., & Scheier, L. M. (2020) · Cambridge University Press eBooks · doi:10.1017/9781108632591.019
Alejo, V., & Alejo, N. E. V. (2020)
Kroll, S. C., Bennett, C. F., & Klinefelter, T. W. (2021) · Journal of the American Psychiatric Nurses Association · doi:10.1177/10783903211030343
Connecting the dots: Structural and functional connections in healthy and diseased brain
Straathof, M. (2021) · Utrecht University Repository (Utrecht University) · doi:10.33540/877
Clinical and Research Methods in the Addictions
Sussman, S. Y. (2020) · Cambridge University Press eBooks · doi:10.1017/9781108632591.008
Levels of Analysis and Etiology
(2020) · Cambridge University Press eBooks · doi:10.1017/9781108632591.014
Ongoing and Future Research Directions
(2020) · Cambridge University Press eBooks · doi:10.1017/9781108632591.030
Sussman, S. Y. (2020) · Cambridge University Press eBooks · doi:10.1017/9781108632591.002
Srivastava, A. B., & Gold, M. S. (2020) · Cambridge University Press eBooks · doi:10.1017/9781108632591.033
Sussman, S. Y. (2020) · Cambridge University Press eBooks · doi:10.1017/9781108632591.042
Shavitt, R. G. (2020) · Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature · doi:10.3410/f.727864723.793580414
Velázquez-Sánchez, C., Mureşan, L., & Belin, D. (2022) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2022.09.13.507749
Modelling Transition From Normal To Epileptic Eeg Signals: A Neuron-Astrocyte Mass Action Approach
Agboola, H., Solebo, C., Aribike, D. S., Lesi, F., & Susu, A. A. (2018) · Proceedings of the Nigerian Academy of Science · doi:10.57046/sfah7243
T-cell deficiency induces deficits in social behavior and dyslipidemia in mice
Asami, S., Tsutsui, Y., Yamamoto, S., & Miyajima, M. (2023) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2023.01.059
A GENÉTICA E O TRANSTORNO OBSESSIVO COMPULSIVO: ESTUDOS CLÁSSICOS E MOLECULARES
Kohlrausch, F. B. (2023) · Editora Científica Digital eBooks · doi:10.37885/230312474
Ciências Biológicas e da Saúde: integrando saberes em diferentes contextos - Volume 3
Barbosa Neto, O., Praxedes, M. F. D. S., Silva, P. F. D., & Carvalho Junior, F. F. D. (2023) · Editora Científica Digital eBooks · doi:10.37885/978-65-5360-335-6
A Review on Obsessive Compulsive Disorder: Neurotransmitters, Biomarkers and Pharmacotherapy
Singh, M., Majhi, S., & Kataria, R. (2023) · Current Indian Science · doi:10.2174/012210299x256025231010053232 · Cited by 2
Obsessive-Compulsive Disorder Comorbid with Bipolar Disorder
Miyazaki, T., & Ishihara, T. (2023) · Anxiety Disorder Research · doi:10.14389/jsad.15.1_31
Chapter 52. Treatment of Obsessive-Compulsive Disorder
Kayser, R. R., & Simpson, H. B. (2024) · American Psychiatric Association Publishing eBooks · doi:10.1176/appi.books.9781615375523.as52 · Cited by 1
Blacksell, I. A., Vismara, M. E. M., Lim, C. M., Dell’Osso, B. M., Pallanti, S., Hollander, E., Vendruscolo, M., D’Addario, C., Cooper, D., & D’Acquisto, F. (2024) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2024.12.16.628685
Obsessive-Compulsive Disorder and 1H-MRS: A Focus on Brain Glutamate and Gamma-Aminobutyric Acid
Batistuzzo, M. C., Hoexter, M. Q., Otaduy, M. C. G., & de Joode, N. T. (2024) · Springer eBooks · doi:10.1007/978-3-031-32035-4_75-1
Grundlagen der Diagnostik und Therapie
(2024) · Elsevier eBooks · doi:10.1016/b978-3-437-22487-4.16001-0
Song, A., & Hao, L. (2025) · New Journal of Chemistry · doi:10.1039/d4nj05416d
MrgD Receptor Modulates Neurotransmission in the Nigrostriatal PathwayPreprint
Rodrigues‐Ribeiro, L., Oliveira, B. D. S., Santos, K. S. B., Machado, C. A., Nawrocki, A., Santos, M. P., de Miranda, A. S., Guatimosim, C., Larsen, M. R., Santos, R. A. S., et al. (2025) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2025.07.10.664011
Obsessive-Compulsive Disorder and1H-MRS: A Focus on Brain Glutamate and Gamma-Aminobutyric Acid
Batistuzzo, M. C., Hoexter, M. Q., Otaduy, M. C. G., & de Joode, N. T. (2025) · Springer eBooks · doi:10.1007/978-3-031-73368-0_75
Innovative treatment approaches for paediatric obsessive-compulsive disorder
Marazziti, D., Gurrieri, R., Gambini, M., Russomanno, G., Palagini, L., & Mucci, F. (2025) · Expert Opinion on Pharmacotherapy · doi:10.1080/14656566.2025.2591073
Chapter 10. Behavioral Addictions
Farhat, L. C., & Potenza, M. N. (2025) · American Psychiatric Association Publishing eBooks · doi:10.1176/appi.books.9798894550862.lg10
Role of diabetes and altered metabolic homeostasis in age-related dementia
Biswas, T., Ahmed, M. A., Bhowmick, S., & Mondal, S. (2025) · Elsevier eBooks · doi:10.1016/b978-0-443-33355-2.00028-1
Hadi, F., Kashefinejad, S., Kamalzadeh, L., Hoobehfekr, S., & Shalbafan, M. (2021) · Figshare · doi:10.6084/m9.figshare.16935936
de Oliveira, K. C., Camilo, C., Gastaldi, V. D., Sant’Anna Feltrin, A., Lisbôa, B. C. G., de Jesus Rodrigues de Paula, V., Moretto, A. C., Lafer, B., Hoexter, M. Q., Miguel, E. C., et al. (2021) · Figshare · doi:10.6084/m9.figshare.16909878
Altered Connectome Gradient and Its Association with Gene Expression Profiles in Patients with MELAS
Wang, R., Yu, Q., Sun, C., Liu, X., Hu, B., Yang, L., Geng, D., Lin, J., & Li, Y. (2025) · American Journal of Neuroradiology · doi:10.3174/ajnr.a9154
Salvi, J. D. (2026) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2026.1745041
Cui, J., Sun, X.-L., Shi, S., Bai, H., Zhang, W., & Bai, W. (2026) · Scientific Reports · doi:10.1038/s41598-026-38725-y
Similitudes et différences entre le TDAH et le TSA, illustrées par l’étude du défaut d’inhibition
Septier, M. (2019) · theses.fr (ABES) · doi:10.70675/22fe83c2z678fz4b7ezac95z1af4554dfcbf
Bation, R. (2018) · theses.fr (ABES) · doi:10.70675/3c89240bzc242z45f4z9247z73969c8af558 · Cited by 1
Metadata
- Authors
- Pittenger, C., Bloch, M. H., & Williams, K.
- Affiliations
- Yale University (US)
- Corresponding author
- Pittenger, Christopher
- Venue
- Pharmacology & Therapeutics
- Publisher
- Elsevier BV
- Published
- 2011-12
- Volume
- 132
- Issue
- 3
- Pages
- 314-332
- ISSN
- 0163-7258 (ISSN-L)
- PMC
- PMC3205262
- OpenAlex
- W2109125813
- Cited by
- 426
- References
- 229
- Citations by year
- 2026: 30 · 2025: 24 · 2024: 23 · 2023: 31 · 2022: 17 · 2021: 33 · 2020: 65 · 2019: 28 · 2018: 25 · 2017: 26 · 2016: 39 · 2015: 34 · 2014: 25 · 2013: 18 · 2012: 7
- FWCI
- 2.37
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Pharmacology & Therapeutics (publishedVersion)
- PubMed (publishedVersion)
- PubMed Central (acceptedVersion)
- Funders
- National Institute of Mental Health (R34MH083115, K08MH081190, K23MH091240, R25MH077823)
- Topics
- Social Sciences › Psychology › Clinical Psychology › Obsessive-Compulsive Spectrum Disorders
- Social Sciences › Psychology › Clinical Psychology › Psychoanalysis and Psychopathology Research
- Social Sciences › Psychology › Experimental and Cognitive Psychology › Anxiety, Depression, Psychometrics, Treatment, Cognitive Processes
- Keywords
- obsessive-compulsive disorder, glutamate, glutamate dysregulation, treatment-refractory OCD, pathophysiology, excitatory neurotransmission, neuroimaging, animal models, cognitive behavioral therapy, pharmacotherapy
- MeSH terms
- Animals, Clinical Trials as Topic, Drug Evaluation, Preclinical, Humans, Neurobiology, Obsessive-Compulsive Disorder, Randomized Controlled Trials as Topic, Neurotransmitter Agents, Glutamic Acid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review